{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:59:14Z","timestamp":1747184354631,"version":"3.40.5"},"reference-count":51,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:00:00Z","timestamp":1582156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:00:00Z","timestamp":1582156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Therapy"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1111\/dth.13250","type":"journal-article","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T16:06:20Z","timestamp":1580918780000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pattern of response of unresectable and metastatic cutaneous squamous cell carcinoma to programmed death\u20101 inhibitors: A review of the literature"],"prefix":"10.1155","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5072-7695","authenticated-orcid":false,"given":"Paola","family":"Corneli","sequence":"first","affiliation":[{"name":"Dermatology Unit Maggiore Hospital Trieste, University of Trieste Trieste Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5126-8873","authenticated-orcid":false,"given":"Claudio","family":"Conforti","sequence":"additional","affiliation":[{"name":"Dermatology Unit Maggiore Hospital Trieste, University of Trieste Trieste Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Retrosi","sequence":"additional","affiliation":[{"name":"Dermatology Unit Maggiore Hospital Trieste, University of Trieste Trieste Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Vezzoni","sequence":"additional","affiliation":[{"name":"Dermatology Unit Maggiore Hospital Trieste, University of Trieste Trieste Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Meo","sequence":"additional","affiliation":[{"name":"Dermatology Unit Maggiore Hospital Trieste, University of Trieste Trieste Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7798-4368","authenticated-orcid":false,"given":"Vincenzo","family":"Piccolo","sequence":"additional","affiliation":[{"name":"Dermatology Unit Second University of Naples Naples Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Farinazzo","sequence":"additional","affiliation":[{"name":"Dermatology Unit Maggiore Hospital Trieste, University of Trieste Trieste Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Russo","sequence":"additional","affiliation":[{"name":"Dermatology Unit Second University of Naples Naples Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Magaton Rizzi","sequence":"additional","affiliation":[{"name":"Dermatology Unit Maggiore Hospital Trieste, University of Trieste Trieste Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5492-3033","authenticated-orcid":false,"given":"Roberta","family":"Giuffrida","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Medicine University of Messina Messina Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Zalaudek","sequence":"additional","affiliation":[{"name":"Dermatology Unit Maggiore Hospital Trieste, University of Trieste Trieste Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,2,20]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29738"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clsc.2016.11.001"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1614298"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10524.x"},{"issue":"1","key":"e_1_2_4_6_1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1684\/ejd.2017.3209","article-title":"Nivolumab for recurrent cutaneous squamous cell carcinoma: Three cases","volume":"28","author":"Blum V.","year":"2018","journal-title":"European Journal of Dermatology"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14642"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200694"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-017-0424-2"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26837"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.2705"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7010010"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20071190"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.2477"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14371"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.06.022"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra022137"},{"key":"e_1_2_4_18_1","article-title":"CARSKIN: Pembrolizumab as first line therapy in patients with unresectable cutaneous squamous cell carcinoma (cSCC)","volume":"35","author":"Maubec E.","year":"2019","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2019.08.011"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-016-0176-3"},{"key":"e_1_2_4_21_1","first-page":"425","article-title":"Efficacy of pembrolizumab in patients with cutaneous squamous cell carcinoma","volume":"5","author":"Ferrarotto R.","year":"2017","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"e_1_2_4_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602252"},{"key":"e_1_2_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.02.026"},{"key":"e_1_2_4_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.3062"},{"key":"e_1_2_4_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2018.1556465"},{"issue":"11","key":"e_1_2_4_26_1","article-title":"KEYNOTE\u2010629: Phase 2 trial of pembrolizumab in patients (pts) with recurrent or metastatic cutaneous squamous cell carcinoma (cSCC)","volume":"28","author":"Licitra L.","year":"2017","journal-title":"Annals of Oncology"},{"key":"e_1_2_4_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1509268"},{"key":"e_1_2_4_28_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2015.05.013"},{"key":"e_1_2_4_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-1012-5"},{"issue":"4","key":"e_1_2_4_30_1","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/00042728-200404020-00018","article-title":"Chemotherapy in the management of advanced cutaneous squamous cell carcinoma in organ transplant recipients: Theoretical and practical considerations","volume":"30","author":"Martinez J. C.","year":"2014","journal-title":"Dermatologic Surgery"},{"key":"e_1_2_4_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805131"},{"key":"e_1_2_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2017.06.005"},{"key":"e_1_2_4_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-017-1119-6"},{"key":"e_1_2_4_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239"},{"key":"e_1_2_4_35_1","unstructured":"Pembrolizumab in Patients with Locally Advanced or Metastatic Skin Cancer. (2017). Retrieved fromhttps:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT02964559"},{"key":"e_1_2_4_36_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-1768"},{"key":"e_1_2_4_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.9543"},{"key":"e_1_2_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2016.12.020"},{"key":"e_1_2_4_39_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20161462"},{"key":"e_1_2_4_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.1187"},{"key":"e_1_2_4_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16270"},{"key":"e_1_2_4_42_1","doi-asserted-by":"publisher","DOI":"10.1159\/000447508"},{"key":"e_1_2_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30066-3"},{"key":"e_1_2_4_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15352"},{"key":"e_1_2_4_45_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.5118"},{"key":"e_1_2_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.06.110"},{"key":"e_1_2_4_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.3884"},{"key":"e_1_2_4_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000799"},{"key":"e_1_2_4_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709030"},{"key":"e_1_2_4_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14664"},{"key":"e_1_2_4_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709684"},{"key":"e_1_2_4_52_1","first-page":"e13107","article-title":"Patterns of response and acquired resistance to the programmed death\u20101 inhibitor pembrolizumab in stage III metastatic cutaneous squamous cell carcinoma","volume":"8","author":"Zalaudek I.","year":"2019","journal-title":"Dermatologic Therapy"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdth.13250","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dth.13250","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dth.13250","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dth.13250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T03:02:58Z","timestamp":1722394978000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.13250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,20]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.1111\/dth.13250"],"URL":"https:\/\/doi.org\/10.1111\/dth.13250","archive":["Portico"],"relation":{},"ISSN":["1396-0296","1529-8019"],"issn-type":[{"type":"print","value":"1396-0296"},{"type":"electronic","value":"1529-8019"}],"subject":[],"published":{"date-parts":[[2020,2,20]]},"assertion":[{"value":"2019-09-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}